ARCHIVES

FDA Approves Abbott’s HER-2 DNA Probe Kit.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

Henry Kaplan Was One Of The Century’s Top Scientists, DeVita Says

March 23, 1984

ASCO Report Urges 5% Annual Increase For NIH.

December 8, 2006

NCI To End CIS Partnership Program In 2010.

December 5, 2008